<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-80642</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pregestational diabetes: perinatal and metabolic results according to the therapy used</dc:title>
<dc:description xml:lang="en">Aim. To evaluate the treatment of pregestational diabetes mellitus (PDM) and the metabolicperinatal results according to the treatment used. Material and method. We reviewed 42 women with PDM with intensive insulin treatment under clinical supervision from the first three months of their pregnancy. Results. The average age was 30±5 years and the time for the average development of diabetes was14,2±9.5 years. The Body Mass Index and the need for insulin passed from 26±4.85kg/m2 and 0,56±0.32 U/kg at the beginning to 30±4.5kg/m2 and 0.70±0.28 U/kg at the end. Prior HbA1c was 7.71±1.85% and a gestational average HbA1c of 6.81±1.33%. Four types of insulin therapy were used: NPH-lispro 26.2%, pre-programmed mixtures 26.2%, glargina-lispro 21.4% and ISCI 26,2%. Significant differences were not found among the types of insulin and the variables analyzed. Conclusions. The type of insulin doesn&#146;t affect perinatal results. High HbA1c are related to greater abdominal circumference at 32 weeks and with a greater (AU)</dc:description>
<dc:creator>Aguilar Diosdado, Manuel</dc:creator>
<dc:creator>Reyes Benítez, M. Josefa</dc:creator>
<dc:creator>Roca Rodríguez, M. del Mar</dc:creator>
<dc:creator>Caballero Frejo, Sol</dc:creator>
<dc:creator>Hervías Vivancos, Blas</dc:creator>
<dc:creator>Amor García Valero, M. del Amor</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Evaluar el tratamiento de la diabetes pregestacional (DPG) y los resultados metabolicoperinatales en función del mismo. Marterial y métodos. Se analiza a 42 mujeres con DPG en tratamiento insulínico intensivo seguidas desde el primer trimestre de gestación. Resultados. La edad media fue de 30±5 años y el tiempo medio±desviación estándar de diabetes fue de 14,2±9,5 años. El índice de masa corporal (IMC) y los requerimientos de insulina pasaron de 26±4,85kg/m2 y 0,56±0,32 U/kg al inicio a 30±4,5kg/m2 y 0,70±0,28 U/kg al final. La hemoglobina glucosilada (HbA1c) previa era de 7,71±1,85% y la media gestacional de 6,81±1,33%. Se aplicaron 4 modalidades de insulina: NPH-lispro 26,2%, mezclas prefijadas 26,2%, glargina-lispro 21,4% e ISCI 26,2%. No hubo diferencias significativas entre el tipo de insulina y las variables analizadas. Conclusiones. El tipo de insulina no afecta a los resultados perinatales. Las HbA1c elevadas se relacionan con mayor circunferencia abdominal a las 32 semanas y más incidencia de partos pretérmino (AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);53(7): 255-260, jul. 2010. tab</dc:source>
<dc:identifier>ibc-80642</dc:identifier>
<dc:title xml:lang="es">Diabetes pregestacional: resultados metabolicoperinatales según la terapia empleada</dc:title>
<dc:subject>^d3954^s22012</dc:subject>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d28620</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d3954^s22016</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24542</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d7925^s22080</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d30157^s22067</dc:subject>
<dc:subject>^d11688^s22057</dc:subject>
<dc:subject>^d30157^s22044</dc:subject>
<dc:subject>^d7500^s22073</dc:subject>
<dc:subject>^d19165^s22080</dc:subject>
<dc:subject>^d3944^s22057</dc:subject>
<dc:subject>^d3944^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201070</dc:date>
</metadata>
</record>
</ibecs-document>
